BCMAS EXAM QUESTIONS LATEST
AND ANSWERS 2026 - 2027
What is an example of cost-effectiveness analysis (CEA)?
A) Comparing costs of Drug A and Drug B, which have evidence of
equal efficacy for a given condition and safety (e.g., incidence of ADRs)
B) Comparing chemotherapy regimens
C) Clinical pharmacy service vs. other institutional service
D) Osteoporosis Drug A versus Drug B on fracture risk reduction
($/fracture avoided) - ANSWERS-D
During what phase of the research process do MSLs typically begin
surveillance of a specific therapeutic area or compound? - ANSWERS-
Phase II
What is a study's perspective? - ANSWERS-It describes the types of
costs relevant to the study's purpose with respect to perspectives of the
institution and payer
Ryan is applying for an educational grant to implement a naloxone
training program for healthcare professionals. Which of the following is
the first step in Ryan's grant process? - ANSWERS-Pre-award
Which statements about generic drugs are true? Select all that apply.
END OF
PAGE
1
, BCMAS EXAM QUESTIONS LATEST
AND ANSWERS 2026 - 2027
A) The quality must be the same as the comparable brand name drug.
B) They must demonstrate greater safety than the comparable brand
name drug.
C) The dosage form must be the same as the comparable brand name
drug.
D) The strength must be lower than the comparable brand name drug.
E) The intended use must be the same as the comparable brand name
drug. - ANSWERS-A, C, E
At what point in a drug's lifecycle does the 20-years of patent protection
begin? - ANSWERS-The date the company files the patent
Meeting follow-ups should take place 24-48 hours after the meeting and
should at least include Select all that apply.
A) potential of additional follow-ups
B) recap of the discussion
C) responses to unanswered medical information questions
D) additional off-label information that might be pertinent to the original
discussion - ANSWERS-A, B, C
END OF
PAGE
2
, BCMAS EXAM QUESTIONS LATEST
AND ANSWERS 2026 - 2027
What US federal law is violated when off-label drug information is
prompted by the manufacturer that is considered to be solicited? -
ANSWERS-FD&C Act
What type of manufacturers conduct research and manufacture drugs
under licenses from other companies? - ANSWERS-CRAMS (Contract
research and manufacturing services)
T/F: Post-Marketing Trials may be more complicated and time
consuming than Phase III Clinical Trials. - ANSWERS-True
Most commonly used study design: - ANSWERS-parallel
Under what conditions can a pharma company provide financial support
for conferences and CME? - ANSWERS-The grants/contributions are
separate from other company funds
The company has had no control over the selection of content, faculty,
or venue
END OF
PAGE
3
, BCMAS EXAM QUESTIONS LATEST
AND ANSWERS 2026 - 2027
Not required by ADR reporting: - ANSWERS-careful selection of
clinical trial participants
Required:
-recognition of events
-safety signals are identified against a background of events
-accurate reporting
Individual board members are known as: - ANSWERS-advisors
in vitro diagnostic test - example - ANSWERS-microbiology culture
in vitro versus in vivo - ANSWERS-in vitro describes something "in
glass" such as a test tube or petri dish
in vivo is "within a living organism"
Fundamental requirement for ongoing risk evaluations of REMS: -
ANSWERS-timely data collection
END OF
PAGE
4
AND ANSWERS 2026 - 2027
What is an example of cost-effectiveness analysis (CEA)?
A) Comparing costs of Drug A and Drug B, which have evidence of
equal efficacy for a given condition and safety (e.g., incidence of ADRs)
B) Comparing chemotherapy regimens
C) Clinical pharmacy service vs. other institutional service
D) Osteoporosis Drug A versus Drug B on fracture risk reduction
($/fracture avoided) - ANSWERS-D
During what phase of the research process do MSLs typically begin
surveillance of a specific therapeutic area or compound? - ANSWERS-
Phase II
What is a study's perspective? - ANSWERS-It describes the types of
costs relevant to the study's purpose with respect to perspectives of the
institution and payer
Ryan is applying for an educational grant to implement a naloxone
training program for healthcare professionals. Which of the following is
the first step in Ryan's grant process? - ANSWERS-Pre-award
Which statements about generic drugs are true? Select all that apply.
END OF
PAGE
1
, BCMAS EXAM QUESTIONS LATEST
AND ANSWERS 2026 - 2027
A) The quality must be the same as the comparable brand name drug.
B) They must demonstrate greater safety than the comparable brand
name drug.
C) The dosage form must be the same as the comparable brand name
drug.
D) The strength must be lower than the comparable brand name drug.
E) The intended use must be the same as the comparable brand name
drug. - ANSWERS-A, C, E
At what point in a drug's lifecycle does the 20-years of patent protection
begin? - ANSWERS-The date the company files the patent
Meeting follow-ups should take place 24-48 hours after the meeting and
should at least include Select all that apply.
A) potential of additional follow-ups
B) recap of the discussion
C) responses to unanswered medical information questions
D) additional off-label information that might be pertinent to the original
discussion - ANSWERS-A, B, C
END OF
PAGE
2
, BCMAS EXAM QUESTIONS LATEST
AND ANSWERS 2026 - 2027
What US federal law is violated when off-label drug information is
prompted by the manufacturer that is considered to be solicited? -
ANSWERS-FD&C Act
What type of manufacturers conduct research and manufacture drugs
under licenses from other companies? - ANSWERS-CRAMS (Contract
research and manufacturing services)
T/F: Post-Marketing Trials may be more complicated and time
consuming than Phase III Clinical Trials. - ANSWERS-True
Most commonly used study design: - ANSWERS-parallel
Under what conditions can a pharma company provide financial support
for conferences and CME? - ANSWERS-The grants/contributions are
separate from other company funds
The company has had no control over the selection of content, faculty,
or venue
END OF
PAGE
3
, BCMAS EXAM QUESTIONS LATEST
AND ANSWERS 2026 - 2027
Not required by ADR reporting: - ANSWERS-careful selection of
clinical trial participants
Required:
-recognition of events
-safety signals are identified against a background of events
-accurate reporting
Individual board members are known as: - ANSWERS-advisors
in vitro diagnostic test - example - ANSWERS-microbiology culture
in vitro versus in vivo - ANSWERS-in vitro describes something "in
glass" such as a test tube or petri dish
in vivo is "within a living organism"
Fundamental requirement for ongoing risk evaluations of REMS: -
ANSWERS-timely data collection
END OF
PAGE
4
